ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test
Introduction to the ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test
The ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test is a cutting-edge genetic test that plays a crucial role in diagnosing Moyamoya disease, a rare and progressive cerebrovascular disorder characterized by stenosis or occlusion of the internal carotid arteries and their major branches. This disorder can lead to significant neurological deficits, including strokes, transient ischemic attacks, and cognitive impairment. Early diagnosis through genetic testing is vital for effective management and intervention.
What the Test Measures
This genetic test specifically detects mutations in the ACTA2 gene, which have been associated with Moyamoya disease. By analyzing the genetic material from a blood sample, the test identifies any pathogenic variants that may contribute to the development of this condition.
Who Should Consider This Test?
The ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test is recommended for individuals who exhibit the following:
- Symptoms of cerebrovascular disorders, such as headaches, seizures, or transient ischemic attacks.
- A family history of Moyamoya disease or related vascular conditions.
- Neurological symptoms without a clear cause.
Benefits of Taking the Test
Undergoing the ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test offers several benefits:
- Early detection of genetic predispositions allows for timely intervention.
- Informs treatment options and management strategies for affected individuals.
- Provides valuable information for family planning and genetic counseling.
Understanding Your Results
Upon completion of the test, results will be analyzed and interpreted by genetic specialists. A positive result indicates the presence of a mutation in the ACTA2 gene linked to Moyamoya disease, while a negative result suggests no identified genetic predisposition. It is essential to discuss the results with a healthcare provider for appropriate guidance and management options.
Pricing Information
Test Name | Discount Price | Regular Price |
---|---|---|
ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Book Your Test Today!
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Our dedicated team is ready to assist you with the ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test. For more information or to schedule your test, please call or WhatsApp us at +254711564616.
Don’t wait for symptoms to worsen; take control of your health today!